Lv0
0 积分 2025-07-16 加入
Factors influencing monoclonal antibody pharmacokinetics across varying immune perturbations
14小时前
待确认
Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement
2个月前
已完结
First-in-Class Antigen-Specific Extracellular Protein Degrader, BHV-1400 for IgA Nephropathy, Selectively Targets Galactose-Deficient IgA for Rapid and Efficient Endolysosomal Degradation in the Liver
3个月前
已完结
Bioavailability and bioactivity of intravenous vs subcutaneous infusion of growth hormone in GH‐deficient patients
4个月前
已完结
Preclinical translational physiologically based pharmacokinetic modeling for predicting human pharmacokinetics of proteolysis targeting chimeras: Case studies of vepdegestrant (ARV-471) and bavdegalutamide (ARV-110)
4个月前
已完结
Clinical Translation of Targeted Protein Degraders
4个月前
已完结
The pharmacokinetics and pharmacodynamics of monoclonal antibodies--mechanistic modeling applied to drug development
4个月前
已关闭
Pharmacodynamic model of slow reversible binding and its applications in pharmacokinetic/pharmacodynamic modeling: review and tutorial
9个月前
已完结
Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption
9个月前
已完结
A next generation mathematical model for the in vitro to clinical translation of T-cell engagers
1年前
已完结
皖公网安备34019202002308
